Loading asset research
Pelthos Therapeutics Inc. Common Stock
PTHSNYSE · USD · StocksQuote as of · Exchange session not verified$21.90
-2.36%
Today
PTHS
Loading 1D prices…
Market cap
$83.8M
Volume
18.9K
52w high
$37.5052w low
$18.19Company profile
Pelthos Therapeutics Inc. Common Stock
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older; XEPI, (ozenoxacin) cream, a quinolone antimicrobial for the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes in adult and pediatric patients 2 months of age and older; and XEGLYZE, a pediculicide indicated for topical treatment of head lice infestation in patients 6 months of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
NYSE
Display currency
USD
Location
Durham, NC, United States
Employees
92
Fiscal year end
1231
CIK
1919246
Session & valuation
Open$22.62
Previous close$22.43
Day high$23.12
Day low$21.21
30-day avg. volume67.5K
Outstanding shares3.8M
Diluted EPS-$23.04
Latest annual period
P/E (trailing)-0.95
P/E (forward)-3.85
Price / book-54.21
Beta3.05
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2836
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| KLRSKalaris Therapeutics Inc. Common Stock | $80.5M | $0.00 | — | -$2.85 | +2.42% | Buy |
| BSEMBioStem Technologies Inc. Common Stock | $76.9M | $301.8M | +10.56% | $1.47 | +3.23% | Buy |
| CGTXCognition Therapeutics Inc. Common Stock | $93.5M | $0.00 | — | -$0.32 | +0.31% | Buy |
| CRDFCardiff Oncology Inc. Common Stock | $94.1M | $593K | -7.73% | -$0.69 | +0.41% | Hold |
| ATRAAtara Biotherapeutics Inc. Common Stock | $94.2M | $120.8M | +27.07% | $2.57 | -5.16% | Buy |